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Schlegel A et al. describe a newly formulated donation after cardiac death (DCD) 
liver transplantation predictive index, which may redefine futility in DCD liver 
transplantation1. Death on the waiting list and organ scarcity have encouraged 
the use of “marginal” grafts, a term that encompasses the DCD liver1. Contrary to 
the initial reports, mounting experience from centers with high volume DCD 
programs demonstrate that DCD vs. donation after brain death (DBD) graft 
survival equivalence can be attained2-4. Understanding how this is achieved is 
fundamental to standardizing the risk of DCD liver transplantation. The authors 
are to be congratulated on their DCD predictive model and the utilization of large 
datasets from National Health Service Blood and Transplant (NHSBT) and 
United Network for Organ Sharing (UNOS) for validation. They demonstrate 
seven parameters (donor age, donor BMI, functional warm ischemic time, cold 
ischemic time, laboratory MELD, recipient age and retransplantation status), 
which can be objectively determined prior to implantation to be associated with 
DCD futility. Many of these factors are acknowledged variables for graft survival 
and are already used by the clinician when judging graft suitability for a given 
recipient. 
 
It is interesting that this DCD Risk Score model has been validated on the UNOS 
database, considering the significant variability in organ procurement techniques 
across USA transplant programs, lack of consensus on donor fWIT and varying 
DCD withdrawal protocols. For example, in the USA, withdrawal of life support 
commonly occurs in the operating room and heparin is routinely given prior to 
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withdrawal. This is in contrast to UK practice where withdrawal occurs in the 
anaesthetic room or at the intensive care unit and heparin is only given after 
death in organ preservation fluid. Additional organ procurement events with 
potentially significant impact on graft outcome, such as endobiliary flush for 
cholangiopathy minimization and short donor hepatectomy times, are typically 
unaccounted for variables when comparing International DCD datasets.  
 
Another aspect that adds to the complexity in developing a globally applicable 
DCD predictive model is that definitions of time intervals that are potentially 
critical to the outcome, such as the donor functional warm ischemic time (fWIT), 
vary widely. The inconsistency in definitions and terminology in DCD donation 
had already been identified and had resulted in the establishment of the 
European Working Group in 2012 including experts from the UK, Spain, France 
and Eurotransplant, supported by the European Commission. Aim of the Working 
Group was to conclude to a consensus agreement on the definitions and 
terminology regarding DCD organ donation. Their work was presented at the 6th 
International Conference on Organ Donation after Circulatory Death held in Paris 
in 20135. This has certainly facilitated more consistent usage of terms in DCD 
donation. Nevertheless, fWIT recording, definition and acceptable range remain 
variable and dependent upon the organ procurement teams. For example, King’s 
fWIT definition is from oxygen saturation of 70% and/or systolic of 50mmHg or 
less to aortic cannulation. Many others will base start of donor fWIT on systolic 
pressure alone or from time of withdrawal to aortic cannulation. Stringency on 
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donor fWIT appears to be an important element of cholangiopathy 
minimization6,7.  
 
In all three DCD predictive models described (UCLA, Kings, Birmingham), four 
variables are shared: fWIT, cold ischemic time (CIT), recipient laboratory MELD, 
and re-transplantation1, 7, 8. Both UCLA and Kings included HCV status, but this 
parameter is already becoming obsolete in the era of direct acting antivirals. 
Normothermic machine perfusion might further mitigate the insult of prolonged 
fWIT and CIT to the DCD graft outcome, but this is yet to be elucidated. King’s 
DCD model further stratified risk according to underlying liver failure etiology, 
which might purely reflect primary liver disease recurrence risk, but may also 
represent the influence of recipient milieu/disease status on 
regenerative/recovery capacity of the DCD liver. Similarly, the use of laboratory 
MELD in all of these DCD models maybe regarded as a surrogate marker for a 
favorable recipient environment for liver recovery. Highlighting that the cellular 
basis of liver recovery/regeneration in transplant still remains ill understood, as 
no additional objective measure of this aspect has yet to be introduced into 
clinical practice. 
 
The wording of futility has to be used in carefully in liver transplantation, for most 
it means less than 50% survival at 5 years. All authors agree that 
retransplantation increases graft loss risk after DCD transplant. But inferior 
survival in liver retransplantation is well established9, 10. It may be worthwhile to 
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confirm if retransplantation survival is inferior after DCD as opposed to DBD liver 
transplantation, independently of CIT. In some recipients awaiting 
retransplantation, the window of opportunity is small and then the only chance of 
survival remains with a DCD liver. Another inherent limitation in all the developed 
DCD predictive models is that they are founded on skewed datasets as clinicians 
already balance the donor recipient risk. Additionally, steatosis has not been 
included in any of the models and in routine practice liver steatosis is a common 
reason for DCD liver decline; the assessment of which remains highly subjective 
and not related to the functional capacity of the liver. 
 
To move DCD liver transplantation forward there needs to be a standardization of 
practice, nomenclature and data collection. However, all of the DCD predictive 
models developed to date do confirm that the fundamental principles of good 
outcome after DCD liver transplantation are based on fastidious donor 
procurement, attention to ischemic times (warm/cold) and recipient selection.  
Ultimately, the addition of objective tests that define the functional/recovery 
capacity of the DCD liver will give foundation to donor recipient algorithms of the 
future. 
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